Delivery Order SPE2DB24D2003-SPE2DB25FXMX0
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,047.70 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) on June 2, 2025, with completion expected by June 3, 2025. This firm fixed-price delivery order, which involves no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $73,667 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a completion date of September 15, 2025. This non-set-aside competitive award was issued on September 12, 2025, for delivery to the Conshohocken, Pennsylvania location. The products represent specialized diabetes management medical devices that support military and veteran healthcare systems through the federal...
- The Defense Logistics Agency awarded a $33,921.62 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5, 5-unit packs) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,190.25 to AmerisourceBergen Drug Corp on September 4, 2025, for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The delivery will be fulfilled from the vendor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $7,762.89 to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7G6 Pods (Generation 5) with a 5-second functionality. This competitively awarded, firm fixed-price delivery order was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,715.24 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin infusion pump pods (Generation 5) with a completion date of August 28, 2025. This non-competed delivery order utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is positioned as a critical vendor...
- The Defense Logistics Agency awarded a $8,655.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5, 5-pack configuration) on August 25, 2025, with completion scheduled for August 26, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,983.80 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a 5-sensor configuration. The contract was competitively awarded without set-aside designation and carries a completion date of June 10, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,184.11 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This non-competitive delivery order, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed price transaction under DLA's pharmaceutical supply chain. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $6,926.84 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods, with performance at the vendor's Conshohocken, Pennsylvania facility. This firm fixed-price, competitively awarded delivery order is scheduled for completion by May 13, 2025, and represents a continuation of supply support under AmerisourceBergen's broader pharmaceutical distribution mandate for federal medical procurement. This...